Drug Approval | April 23, 2026
Cipla’s generic Ventolin HFA secures USFDA approval
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The programme integrates simulation-based training, expert-led sessions, and case-based discussions
The plant is currently scaling towards a production capacity of nearly 3 million gloves per day
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
PMDA is regarded among the most stringent regulatory bodies globally
Move strengthens footprint in Western India and expands multi-specialty care network
The programme is being implemented in collaboration with Grow Well Foundation and is expected to expand in a phased manner
Acquires 85% stake in the formulations company valued at Rs 200 crore enterprise value; founder Vivek Seth to retain 15%
Subscribe To Our Newsletter & Stay Updated
